Article

FDA approves new B&L contact lens material

The FDA has cleared the use of the new Bausch & Lomb (B&L) Boston XO2 gas-permeable contact lens material for daily wear in patients with ametropia and certain irregular corneal conditions, the company announced.

Rochester, NY-The FDA has cleared the use of the new Bausch & Lomb (B&L) Boston XO2 gas-permeable contact lens material for daily wear in patients with ametropia and certain irregular corneal conditions, the company announced.

Lenses made with this new contact lens material allow 40% more oxygen to reach the eye than the original Boston XO material, said the eye-care company, which is being acquired by Warburg Pincus

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.